Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Sun Pharma and hold GMR Infra.
Mitessh Thakkar of mitesshthakkar.com told CNBC-TV18, "Let us go back to March 2015 when Sun Pharma was about Rs 1120-1130 levels and then we have seen a big correction. The stock has more than halved. Now it is showing some signs of a reversal, I hope it sustains this time. It has had some false dawns earlier as well but it looks like that this stock could now possibly get into a short to medium term uptrend, so you can buy more, keep a stop loss below levels of Rs 495-500, that being the support zone."
"On the upside, I think targets could be roughly around Rs 625. In case we get past Rs 625, we can even look at Rs 700-710 happening but that is something which I will possibly know in time to come by. For the time being I would suggest Rs 625 should be the target and try to add it around Rs 520-530 zones on a bad day when there is some kind of USFDA announcement or something like that."
"Lot of these beaten down stocks specially the infra names – JP Associates and GMR Infra have at least reversed from their lows at which they were trading at about a year and a half back. So, in that sense there is some kind of a medium term upmove going on."
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .